Kiora Pharmaceuticals Inc. (KPRX)
Market Open
12 Jun, 13:54
NASDAQ (CM) NASDAQ (CM) Primary $
2. 51
-0.09
-3.4308%
$
11.48M Market Cap
0.69 P/E Ratio
- Div Yield
2 Volume
-1.74 Eps
$ 2.6
Previous Close Want to track KPRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 0.38 |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
KPRX Earnings Reports FAQ
What is the earnings per share (EPS) for KPRX?
The current EPS is -1.74.
What is the company's earnings growth rate?
Kiora Pharmaceuticals Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Kiora Pharmaceuticals Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Kiora Pharmaceuticals Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for KPRX at this time, as Kiora Pharmaceuticals Inc has no recent EPS data to calculate it.
